Posts Tagged ‘patients’

In a recent blog post, I mentioned the three critical themes for success in the digital age, as identified by McKinsey & Company through interviews with 20 pharma executives: 

I enjoy reading FDA Warning Letters. They’re insightful and often entertaining. Sometimes, though, they’re kind of unbelievable. And, sometimes, they’re downright nauseating. Take, for example, this letter issued on February 19, 2016 to a principal investigator (PI) based in New York. FDA inspectors found him to be in violation of 21 CFR Part 312.62(b), related […]

  At the end of 2015, Austin Frakt, a health economist, researcher, and contributor to The New York Times’ The Upshot, wrote about the life sciences industry’s lack of interest in developing medicines that prevent cancer. 

  As we mentioned in our life sciences trends guide for 2016, patient recruitment is a constant challenge that needs to be confronted head-on with innovative tactics and technology. The mere fact that only 5% of cancer patients ever enroll in a trial is simply unacceptable, considering how connected we are in the digital era. 

  Multiple Myeloma Research Foundation (MMRF) founder Kathy Giusti attended the Precision Medicine Initiative (PMI) summit several weeks ago, which was hosted by President Barack Obama. In a Forbes guest post, she shared five reasons why we can be optimistic about the initiative, which aims to develop better, targeted therapies that leverages one’s unique genetic […]

  Booz Allen Hamilton, a management and technology consulting firm, believes that hyper-personalization, the ability to leverage analytics and other digital methods to communicate on a one-to-one level, will be a trend for 2016. We agree. For example, portals will offer patients and their caretakers the information they want when they want it. 

BIO, the world’s largest trade association representing biopharmaceutical and research organizations, put out a compelling integrated marketing campaign that shows you shouldn’t put a price tag on life. 

A recent study published in American Academy of Pediatrics found that providing Asthma patients with medication before they left the hospital reduced ER re-admission rates, as opposed to the standard method of relying on patients to fill their own prescriptions. Medication adherence is a topic that we talk a lot about because of the significant impact […]

It’s not easy to sift through and make sense of the vast amount of data posted each day by patients or their caregivers via social media. When it comes to unstructured data (e.g., abbreviations and acronyms), it’s even more difficult. However, it’s critical to evaluate the constant chatter to help detect or prevent possible issues, […]

  Jeffrey Keisling, CIO and SVP at Pfizer, recently wrote an article in CIOReview that discussed the technological ingredients it takes to drive innovation. The pharmaceutical giant’s Business Technology group coined it “Formula Five.” 

  Dr. Robert Califf, a cardiologist who has spent most of his career at Duke University, was confirmed by the Senate on February 24, 2016, to be the next FDA commissioner, following President Barack Obama’s nomination in September 2015. 

  Patients who are being treated for diseases, such as cancer, often require multiple drugs to manage their conditions. For example, patients are often prescribed drugs that treat the actual disease, while others are meant to manage side effects from those drugs. Many of these patients can probably attest to inquiring about or doing their […]